Brief: ABL Texcell Diagnostics Announces Proposed Acquisition Of Vela Diagnostics In Singapore, US
21/09/2026 18:55
BRIEF-ABL Texcell Diagnostics Announces Proposed Acquisition Of Vela Diagnostics In Singapore, US Sept 21 (Reuters) - ABL Texcell Diagnostics:
ABL TEXCELL DIAGNOSTICS REACHES A NEW STRATEGIC MILESTONE WITH A PROPOSED ACQUISITION OF VELA DIAGNOSTICS' ACTIVITIES IN SINGAPORE AND THE UNITED STATES
ABL TEXCELL DIAGNOSTICS SA - SIGNS NON-BINDING LETTER OF INTENT TO BUY 100% OF VELA OPERATIONS SINGAPORE AND VELA DIAGNOSTICS USA
ABL TEXCELL DIAGNOSTICS SA - NO CHANGE IN CONTROL OR GOVERNANCE OF ABL TEXCELL DIAGNOSTICS OR ADVANCED BIOLOGICAL LABORATORIES
ABL TEXCELL DIAGNOSTICS SA - PARTIES TO CONTINUE DUE DILIGENCE AND DISCUSSIONS ON DEFINITIVE DEAL DOCUMENTATION
Source text: ID:nBw2N7wJfa
Further company coverage: ABLD.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AbL Diagnostics SA
See all newsBrief: Abl Texcell Diagnostics Raises Its 2026 Revenue Guidance To €13.5 Million - €14.0 Million
Brief: ABL Texcell Diagnostics Announces Proposed Acquisition Of Vela Diagnostics In Singapore, US
Brief: ABL Diagnostics - Changes Name To ABL Texcell Diagnostics
Brief: ABL Diagnostics (ABLD) Announces The Filing Of A Takeover Bid For Integragen
Brief: ABL Diagnostics Delays Half-Yearly Accounts To 30 June 2023